Mitiglinide Calcium Hydrate/Voglibose

米格列奈钙/伏格列波糖

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMitiglinide Calcium Hydrate/Voglibose
Drug Alias NameMitiglinide Calcium/Voglibose伏格列波糖/米格列奈钙伏格列波糖米格列奈钙Voglibose/Mitiglinide CalciumMitiglinide Calcium and Voglibose +[9] 
ClassificationSmall molecules
Mechanisms of ActionPotassium channel blockersMaltase-glucoamylase inhibitorsVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channelMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2011/04/22
Country/TerritoryJapan
CombinationsYes VogliboseMitiglinide
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKissei Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10B
Related LinksKEGG